EORTC

European Organisation for #Research and #Treatment of #Cancer defines better treatments for all cancer #patients to prolong survival and improve quality of life

[EORTC @EORTC]

📅 Save the date!

EORTC events are back in 2026 ⬇️

#CancerResearch #ClinicalTrials #Oncology #EORTCevents

[EORTC @EORTC]

Strong research needs strong leaders.

40 investigators from 16 countries selected for EORTC's Y-ECI 2027 programme!

Thanks to Princess Laetitia and our donors for supporting future cancer research leaders.

https://t.co/hEiQ4Y23P2

#ECRF

[EORTC @EORTC]

🎗️🫁 November is #LungCancerAwarenessMonth!

In 2024, an estimated 2.6M people were diagnosed with lung cancer and 1.9M died worldwide. At EORTC Lung Cancer Group, we advance prevention, early detection and research.

Learn more: https://t.co/NAv7fjG6p7

#EORTClung

[EORTC @EORTC]

📢 SAVE THE DATE MCCR 2027

MCCR returns on 20–24 June 2027 in the Netherlands for a week of expert-led training in clinical trial design!

@myESMO @AACR

🗓️ Applications: 1 December 2026
🔗 https://t.co/bIlQkrk5qb

#MCCRworkshop #ClinicalTrialDesign

[EORTC @EORTC]

🚀 Pilot access is now open for EORTC PROcoach, our new e-learning course on the use of patient-reported outcome measures in clinical practice.

👉 Explore the course and share your feedback to help shape its final development: https://t.co/MQjPWkPpZ4

#QualityofLife @EORTC_QLG

[EORTC @EORTC]

📢 Late rate ends 4 November!

Join the international oncology research community at #ENASymp26.

⏰ Register now: https://t.co/73sSXHnXZh

@AACR @theNCI

#CancerResearch #Oncology

[EORTC @EORTC]

We're hiring a Junior Clinical Operations Manager at EORTC.

Help support the planning, coordination and execution of international clinical studies that advance cancer treatment.

📍Brussels, Belgium

👉 Apply here: https://t.co/MMFEIGYI0V

#Hiring #ClinicalResearch #EORTC

[EORTC @EORTC]

📘 How can researchers better involve patients & caregivers in #QualityofLife research?

The new Guidance for Patient Involvement in the @EORTC_QLG offers practical recommendations & resources to support meaningful patient involvement.

🔗 https://t.co/SM2Qx9MLNt

#CancerResearch

[EORTC Quality of Life Group (QLG) @EORTC_QLG]

👏 Proud to see the @EORTC Quality of Life Group featured at the 27th Panhellenic Urology Congress.

By showcasing the EORTC HRQoL measurement system & the QLQ-RCC38 module development, we continue to promote the value of PROs & #QualityofLife research in #CancerCare.

@ISUReHub

[EORTC @EORTC]

🎗️ What quality of life issues matter most to people living with metastatic breast cancer?

This joint study from the EORTC #QualityofLife and #BreastCancer Groups identified key patient priorities and supports development of the EORTC QLQ‑MBR module.

🔗 https://t.co/pZ52AccsgO

[EORTC @EORTC]

The first participating site is now active in #EORTC STARBURST-1. Led by Prof Alexandra Masson-Lecomte and involving 20 centres, this study will investigate mpMRI, NacVI-RADS, tumour DNA and molecular classifications in muscle-invasive bladder cancer.

🔗 https://t.co/jh08NDCy7T

[EORTC @EORTC]

🌍An important EORTC #QualityofLife Group publication led by @csimoes96 and colleagues, proposing a flexible and actionable approach to HRQoL assessment in people diagnosed with solid rare cancers. 👇
#CancerResearch #RareCancers #GivingVoice2Patients @Winette_vdGraaf @OlgaHusson

[EORTC Quality of Life Group (QLG) @EORTC_QLG]

🔍 New @EORTC #QualityofLife Group publication.

In 397 patients across 20 solid rare cancer diagnoses, the EORTC QLQ‑C30 proved relevant for assessing HRQoL, and combining it with tailored item lists may better capture what matters most to patients.

🔗 https://t.co/ba4bDUEQnJ

[EORTC @EORTC]

#ESMO26 concluded yesterday after five days of scientific exchange across the oncology community.

Catch up on the key EORTC studies, presentations and highlights from this year's congress ⬇️

🔗 https://t.co/Yp9g26YK6Q

#EORTC #CancerResearch @myESMO

[EORTC @EORTC]

Presented at #ESMO26: final results from the PEARLS/KEYNOTE-091 study.

Dr Mary O’Brien shared long-term follow-up data on adjuvant pembrolizumab in patients with completely resected stage IB-IIIA NSCLC.

Read the key takeaways from the presentation below ⬇️
#EORTC #NSCLC @myESMO

[EORTC Quality of Life Group (QLG) @EORTC_QLG]

📌 #ESMO26 e-poster spotlight

“Are we measuring the symptoms that matter most to patients? Our analysis shows that existing @EORTC questionnaires capture most common treatment-related symptoms in #HeadNeckCancer.”

Congrats to @mkmoutafi et al. 👏

#GivingVoice2Patients @myESMO

[EORTC @EORTC]

📌 #ESMO26 Poster

How comparable are PFS results across cancer trials?

A systematic review of 156 oncology studies found considerable variation in how intercurrent events were handled & reported, highlighting the need for greater standardisation & transparency.

#CancerResearch

[EORTC @EORTC]

Come and meet us at booth S1041, Hall 10 👋
Find out how to submit your research to #EORTCSummit, explore EORTC membership and discover all the opportunities to get involved in our clinical research. #ESMO26

[EORTC @EORTC]

📢 Call for Abstracts is OPEN for #EORTCSummit 2027!

Submit your research and share it with the clinical cancer research community.

📅 Abstract submission: 30 September – 4 November 2026
👉 https://t.co/bl8I3sNbPm

#CancerResearch #ClinicalResearch #Oncology

[EORTC @EORTC]

At today’s #ESMO2026 Policy session, Iryna Shakhnenko presented findings from an EORTC study on patient partner reviews of informed consent forms across 49 clinical trials.

👏 Congratulations to Iryna on presenting this work.

See the key highlights below. 👇 @myESMO

[EORTC @EORTC]

📄 New in @Hemasphere_EHA
Researchers from the i-BFM Study Group, including contributors from EORTC, identified favorable subgroups of pediatric high-hyperdiploid ALL in a retrospective multinational study that included data from the EORTC-CLG 58951 trial.
https://t.co/qlALnAk7WS

[EORTC @EORTC]

📍 We're in Madrid for #ESMO26!

The EORTC team is at booth S1041 throughout the congress. If you're attending ESMO, stop by to meet the team and learn more about our research and collaborations.

We'd love to see you there! 👋

#EORTC #CancerResearch @myESMO

[EORTC @EORTC]

#ESMO26 Congress opens tomorrow in Madrid.

EORTC researchers and collaborators will present multidisciplinary research across oral presentations, mini orals, posters, e-posters and trials in progress.

Explore our abstract overview: https://t.co/mzLkGEhqlF